Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting treatment for optimal outcome.

S E Husted1

  • 1Department of Internal Medicine and Cardiology, Aarhus University Hospital, Denmark. steen.husted@aas.auh.dk

Clinical Cardiology
|February 19, 2000
PubMed
Summary

Rapid risk stratification for acute chest pain is crucial. The FRISC II trial compared invasive versus non-invasive strategies and anticoagulation durations in unstable coronary artery disease patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dipyridamole and Platelet Release of Platelet-derived Growth Factor.

Platelets·2010
Same author

Improved nutritional status in elderly patients 6 months after stroke.

The journal of nutrition, health & aging·2007
Same author

Long-term anticoagulant therapy in patients with coronary artery disease.

European heart journal·2006
Same author

Severe intoxication after an intentional overdose of amlodipine.

Acta anaesthesiologica Scandinavica·2003
Same author

A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy.

Journal of internal medicine·2002
Same author

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization.

European heart journal·2002

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Diagnostics

Background:

  • Acute chest pain requires rapid assessment to differentiate life-threatening conditions like myocardial infarction from non-acute coronary syndrome cases.
  • Accurate risk stratification aids clinical diagnosis and management decisions for patients with acute chest pain.

Purpose of the Study:

  • To review recent data on techniques for rapid risk stratification in acute chest pain.
  • To evaluate treatment strategies, including invasive versus non-invasive management and anticoagulation duration, in unstable coronary artery disease.

Main Methods:

  • Utilized clinical findings, electrocardiographic monitoring, symptom-limited exercise testing, and biochemical markers for risk stratification.
  • The Fragmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) study compared early invasive versus non-invasive strategies.
  • Assessed outcomes with short-term versus prolonged anticoagulation with dalteparin sodium (Fragmin).

Main Results:

  • The FRISC II trial provided data on clinical outcomes for different management strategies and anticoagulation durations.
  • Combined assessment techniques enhance the value of risk stratification in unstable coronary artery disease.

Conclusions:

  • Risk stratification techniques are vital for managing patients with acute chest pain.
  • Further clinical trials are needed to determine optimal treatment strategies, such as invasive versus medical management, for stratified patient groups.

Related Experiment Videos